```html
Our research group, led by Professor Riitta Lahesmaa, is based at the Turku Bioscience Centre, BioCity Turku, Turku, Finland. We are seeking a motivated postdoctoral researcher for a two-year project funded by The Finnish Research Impact Foundation. During the project, the postdoctoral researcher will have the opportunity to work approximately half the time with Orion in Turku, alongside Orion’s Immuno-oncology team.
Immunotherapy has revolutionized cancer treatment, and the number of cases eligible for immunotherapies is steadily rising. T cells infiltrate the tumor site and launch cytotoxic responses against cancer cells. However, the immunosuppressive tumor microenvironment prevents effective anti-tumor immune responses. In this project, our research group at Turku Bioscience will collaborate with Orion’s immuno-oncology team to discover novel mechanisms responsible for insufficient anti-tumor T-cell responses. Our goal is to find new ways to modulate T-cell responses and identify patients suitable for these innovative therapeutic approaches in the future. We will use a range of methods, including single-cell genomics and computational tools, to address these questions.
The salary is determined by the collective agreement system of Finnish universities. These positions belong to our research personnel, with a salary range of 3450 – 3800 EUR/month for a Postdoctoral Researcher. The position starts on January 1, 2025, and is initially for two years, with a possible extension. There is a six-month trial period.
Please include a CV, full publication list, list of selected publications, and contact information for three references in your application.
For further information, please contact Prof. Riitta Lahesmaa at riitta.lahesmaa (at)utu.fi.
Enquiries about the application procedure may be directed to HR Specialist Paula Luoma at paula.luoma(at)utu.fi. From August 7, 2024, to July 31, 2024, application enquiries will be answered by our central HR services at hr-tuki(at)utu.fi.
The Turku Bioscience Centre is a joint research institute of the University of Turku and Åbo Akademi University. Our mission is to promote high-quality research and training. We have excellent state-of-the-art technology platforms and expertise in single-cell omics, NGS, epigenomics, proteomics, computational biology, and high-end cell imaging and cytometry.
The Orion Immuno-Oncology (IO) Team, led by Dr. Anil Thotakura, is responsible for innovative drug discovery projects, identifying clinical unmet needs, and experimentally validating potential IO drug targets using state-of-the-art laboratories and technologies.
Turku Bioscience is an advanced core facility and research centre hosted jointly by the University of Turku and Åbo Akademi University. Our aim is to provide comprehensive service expertise and know-how to help both academic and corporate research groups shorten the runway from initial discovery to the take-off of a success story. We stay at the forefront of new technologies and research and actively facilitate interactions and joint projects between academia and industry.
The University of Turku is an inspiring and international academic community of 25,000 students and staff in Southwest Finland. We build a sustainable future with multidisciplinary research, education, and collaboration. With us, your work will have a significant impact and relevance in the changing world.
